SMLR vs TLRY · P/E 5.0, rev $56.3M vs rev $915.5M
Semler Scientific Inc (SMLR) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Semler Scientific Inc (SMLR) is a medical devices company listed on NASDAQ.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported SMLR revenue for 2024-12-31 was $56.3M. Net income was $40.9M. SMLR currently screens at market cap $348.3M and trailing P/E 5.0.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
SMLR currently screens at market cap $348.3M and trailing P/E 5.0. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the SMLR and TLRY stock pages for the full models.
Not investment advice.